DISCLAIMER- NO PRESCRIPTION WILL BE PROVIDED UNLESS A CLINICAL NEED EXISTS BASED ON REQUIRED LAB WORK, PHYSICIAN CONSULTATION AND CURRENT MEDICAL HISTORY EITHER THROUGH PATIENT'S PERSONAL PHYSICIAN OR Pharmacy Rx Solutions PHYSICIAN. AGREEING TO LAB WORK DOES NOT AUTOMATICALLY EQUATE TO CLINICAL NECESSITY AND A PRESCRIPTION. No claim or opinion made by PharmacyRx Solutions is intended to be, or should be construed to be medical advice. Please consult with a healthcare professional before starting any therapeutic program.
Developed in the late 1950s, by the renowned oncologist, the late Dr. Manuel D. Navarro, the test detects the presence of cancer cells even before signs or symptoms develop. Dr. Navarro found HCG to be present in all types of cancers.
The test is based on a theory proposed by Howard Beard and other researchers who contend that cancer is related to a misplaced trophoblastic cell that become malignant in a manner similar to pregnancy in that they both secrete HCG. As a consequence, a measure of the amount of HCG found in the blood or urine is also a measure of the degree of malignancy. The higher the number, the greater is the severity of cancer.
Urine, as opposed to blood or serum, is the preferred specimen for the test. In 1980, Papapetrou and co-authors reported the correctness of the urine specimen to be used in HCG Immunoassay. In 32 proven cancer cases, the immunoassay test gave 31 positive results using urine while only 12 positive results were reported using blood. HCG has been found to undergo glycosylation in the liver as it travels in the hepatic circulation. Thus, the HCG molecule cannot be detected. The molecule does not undergo this process in the kidney and therefore the molecule remains intact in the urine.
The test detects the presence of brain cancer as early as early as 29 months before symptoms appear; 27 months for fibro sarcoma of the abdomen; 24 months for skin cancer; 12 months for cancer of the bones (metastasis from the breast extirpated 2 years earlier).
The Navarro Medical Clinic has been performing the HCG test for cancer for many years and continues to offer this service under the direction of Dr. Efren Navarro. Dr. Efren Navarro, the son of the late Dr. Manuel D Navarro is a graduate of Doctor of Medicine from the University of Santo Thomas, School of Medicine and Surgery, Manila Philippines. He finished his residency in Pathology at Mercy Hospital Medical Center in Chicago. In 1994 he became a Hematopathology Fellow at the University of Illinois, Chicago. In 1996, he returned to the Philippines to continue the work of his famous oncologist father, Manuel Navarro, .
Currently, many cancer patients take advantage of the diagnostic accuracy of the HCG test as an indicator of the effectiveness of their specific mode of therapy. Thousands of cancer survivors have used this test over the years to keep track of their treatment(s) success and check on the status of their remission. Patients follow a simple direction for preparing a dry extract from the urine sample. The powdery extract is mailed to the Navarro Medical Clinic where the HCG testing is performed.